Cipla hits fresh 52-week low on 12 USFDA observations Cipla hits fresh 52-week low on 12 USFDA observations Shohini Nath / Monday, September 30, 2019 0 3742 Article rating: 5.0 United States Food and Drug Administration (USFDA) completed inspection at Cipla’s Goa manufacturing facility, with 12 observations. Reacting to the news, the shares of Cipla tumbled over 4 per cent intraday on Monday morning to hit fresh 52-week low of Rs. 418 in BSE. Read more
HCC slips despite inauguration of aircraft carrier dock HCC slips despite inauguration of aircraft carrier dock Shohini Nath / Monday, September 30, 2019 0 1579 Article rating: 4.7 Hindustan Construction Company (HCC) has inaugurated the Indian Navy's first aircraft-carrier dry dock in the city of Mumbai. However, the shares in the morning session on Monday were trading in red. Read more
Tata Power subsidiary wins floating solar project in Kerala Tata Power subsidiary wins floating solar project in Kerala Shohini Nath / Friday, September 27, 2019 0 1901 Article rating: 4.0 Tata Power Solar, Tata Power’s wholly owned subsidiary, has won the bid for 105MWp floating solar energy project in Kerala. Read more
Cipla launches Daptomycin for injection, shares in green Cipla launches Daptomycin for injection, shares in green Shohini Nath / Thursday, September 26, 2019 0 2436 Article rating: 4.5 The pharmaceuticals and drug company, Cipla informed the exchanges on Thursday that it has launched Daptomycin for Injection, 500mg/vial, single-dose vial for intravenous use only. Read more
AstraZenca rallies on receiving nod from Drug Controller AstraZenca rallies on receiving nod from Drug Controller Shohini Nath / Thursday, September 26, 2019 0 2533 Article rating: 5.0 AstraZeneca Pharma India has received import and market permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India. Read more